|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
The study objective was to assess the prevalence of cardiovascular disease risk factors in patients treated for childhood cancer (<i>N</i> = 101) and to determine the involvement of clinical (cancer type and therapy) and/or genetic (<i>FTO</i> gene rs9939609 polymorphism) factors.
|
29675043 |
2018 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
The rs9939609 polymorphism in the FTO gene has recently been implicated as a risk factor for some types of cancer, such as breast, pancreatic, and prostate cancers.
|
29260910 |
2018 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
Besides, in the subgroup analysis of ethnicity, our results indicated that rs9939609 polymorphism was significantly associated with cancer risk in Asians.
|
26931363 |
2017 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
However, <i>FTO</i> rs9939609 variant was associated with some types of cancer in the subgroup analysis.
|
28881622 |
2017 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
GWASCAT |
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.
|
27790247 |
2016 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
Variants (such as rs9939609) in the fat mass- and obesity-associated (FTO) gene have been associated with obesity, type 2 diabetes, some cancers, and alcohol consumption.
|
23771786 |
2013 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
Our meta-analysis indicated that there was no association between FTO rs9939609 polymorphism and the increased risk of c</span>ancer, although this polymorphism was marginally associated with pancreatic cancer.
|
22396042 |
2012 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
Among 22,799 individuals (44-74 years) in the population-based Malmö diet and cancer cohort that were genotyped for rs9939609 in FTO and had information on dietary intake (from a modified diet history method) and no history of diabetes, cancer or cardiovascular disease, 2255 deaths (including 1100 cancer and 674 cardiovascular deaths) occurred during 12.0 years of follow-up.
|
21179003 |
2011 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
The rs9939609 A allele, which was associated with higher BMI in the sample, was inversely associated with overall (odds ratio (OR) versus all controls = 0.93; 95% confidence interval (CI): 0.85-1.02 p = 0.12 per allele) and low-grade (OR = 0.90; 0.81-0.99 p = 0.03 per allele) prostate cancer risk, but positively associated with high-grade cancer among cases (OR high- versus low-grade cancer = 1.16; 0.99-1.37 p = 0.07 per allele).
|
20976066 |
2010 |
|
rs9939609
|
|
|
0.790 |
GeneticVariation |
BEFREE |
A cross-sectional study examined 4839 subjects in the population-based Malmö Diet and Cancer study with dietary data (from a modified diet history method) and information on the genetic variant FTO (rs9939609).
|
19726594 |
2009 |
|
rs1800625
|
|
|
0.720 |
GeneticVariation |
BEFREE |
CONCLUSIONS In conclusion, the RAGE rs1800625 polymorphism was associated with increased overall cancer risk in Asians in recessive genetic model.
|
31534114 |
2019 |
|
rs1800625
|
|
G |
0.720 |
GeneticVariation |
GWASCAT |
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer.
|
26546620 |
2016 |
|
rs1800625
|
|
|
0.720 |
GeneticVariation |
BEFREE |
Therefore, we performed a systematic review to identify statistical evidence of the association between the 3 polymorphisms rs2070600 G/S (82G>S), rs1800624 T/A ( -374 T>A) and rs1800625C/T (-429 C>T) and the risk of cancer.
|
26011358 |
2015 |
|
rs1800625
|
|
|
0.720 |
GeneticVariation |
BEFREE |
We failed to get an effective conclusion about the association between the rs1800624 and rs1800625 polymorphisms and cancer risk in overall comparison.
|
26011358 |
2015 |
|
rs12494691
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study.
|
30277654 |
2018 |
|
rs1641025
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study.
|
30277654 |
2018 |
|
rs10035650
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs10138053
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs10160246
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs10273639
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs1029966
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs10490913
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs10510776
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs10833965
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |
|
rs10854373
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Cancer risk susceptibility loci in a Swedish population.
|
29299148 |
2017 |